Heather Gaudard
Nurse Practitioner · Owosso, MINPI 1225524903
Payments from drug & device makers
Across 178 payments — averaging $24.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$467
- Johnson & Johnson$374
- AbbVie$335
- Medtronic$313
- Convatec Inc.$244
- Teleflex LLC$190
- plus $2K from 35 others
What the payments were for
- Food & beverage$4,03194%
- Education$2536%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 14 | $467 |
| Johnson & Johnson | 15 | $374 |
| AbbVie | 19 | $335 |
| Medtronic | 6 | $313 |
| Convatec Inc. | 6 | $244 |
| Teleflex LLC | 3 | $190 |
| Accord Healthcare, Inc. | 8 | $175 |
| Pfizer | 6 | $175 |
| Sumitomo Pharma America, Inc. | 12 | $173 |
| Myriad Genetic Laboratories, Inc. | 10 | $169 |
| Janssen Scientific Affairs, LLC | 4 | $140 |
| Valencia Technologies Corporation | 1 | $125 |
| Antares Pharma, Inc. | 7 | $112 |
| Dendreon Pharmaceuticals LLC | 4 | $104 |
| Blue Earth Diagnostics | 5 | $100 |
| Urovant Sciences Inc | 6 | $96 |
| Coloplast | 5 | $94 |
| Endo USA, Inc. | 4 | $73 |
| Ferring Pharmaceuticals Inc. | 3 | $68 |
| Endo Pharmaceuticals Inc. | 3 | $57 |
| Avation Medical, Inc. | 1 | $54 |
| Boston Scientific | 2 | $52 |
| Tolmar Pharmaceuticals, Inc. | 3 | $46 |
| Clarus Therapeutics Inc. | 3 | $46 |
| Merck | 2 | $45 |
| Astellas Pharma US Inc | 2 | $45 |
| AstraZeneca | 3 | $44 |
| Amgen | 3 | $39 |
| Tolmar, Inc. | 2 | $35 |
| Novartis | 2 | $35 |
| Progenics Pharmaceuticals, Inc. | 2 | $34 |
| EDAP Technomed Inc | 2 | $33 |
| Bayer | 2 | $32 |
| Avyxa Pharma, LLC | 1 | $29 |
| Telix Pharmaceuticals | 1 | $26 |
| Sanofi | 1 | $22 |
| Urogen Pharma, Inc. | 1 | $21 |
| Healthtronics Stone Solutions, LLC | 1 | $17 |
| Halozyme Inc | 1 | $16 |
| Photocure Inc | 1 | $14 |
| Dentsply IH AB | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$133
- eCoin Device Kit$125
- Axonics$124
- UroLift System$112
- Axonics r-SNM System$104
How this compares
$4,284 in reported general payments places this provider in the 95th percentile of 3,351 nurse practitioner providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XtandiEnzalutamide | 11 | $152,588 |
| GemtesaVibegron | 84 | $83,926 |
| MyrbetriqMirabegron | 99 | $78,190 |
| Mirabegron ErMirabegron | 18 | $9,062 |
| Testosterone | 23 | $7,410 |
| Tamsulosin Hcl | 258 | $5,195 |
| Estradiol | 41 | $4,229 |
| Dutasteride-TamsulosinDutasteride/Tamsulosin Hcl | 16 | $2,939 |
| Trimethoprim | 33 | $2,555 |
| Fosfomycin Tromethamine | 16 | $2,517 |
| Cephalexin | 59 | $2,387 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 23 | $2,349 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 49 | $1,564 |
| Potassium Citrate ErPotassium Citrate | 14 | $1,049 |
| Tolterodine Tartrate ErTolterodine Tartrate | 13 | $969 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncXtandi, Myrbetriq | $45 | $230,778110 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $173 | $83,92684 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,351 nurse practitioner providers in Michigan.
Other nurse practitioner in Owosso
- Paige GouletteOwosso$19K
- Davida KrugerDetroit$1.8M
- Kari HillSpring Lake$426K
- Kyle FarrPlymouth$243K
- Linda SpencerTroy$217K
- Ellen DillardDetroit$168K
- Golbon AghamohammadiDetroit$157K
- Abubakir BabanDearborn$143K
- Elizabeth KirshnerAnn Arbor$119K
- Lisa Astalos ChismWoodhaven$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.